Omnicell Director James Judson Unloads 5,000 Shares (OMCL)
Omnicell (NASDAQ:OMCL) Director James Judson sold 5,000 shares of the stock on the open market in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $23.66, for a total transaction of $118,300.00. Following the transaction, the director now directly owns 17,945 shares in the company, valued at approximately $424,579. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Omnicell (NASDAQ:OMCL) traded up 3.23% on Friday, hitting $24.59. 191,529 shares of the company’s stock traded hands. Omnicell has a 1-year low of $12.61 and a 1-year high of $25.22. The stock’s 50-day moving average is $23.49 and its 200-day moving average is $20.39. The company has a market cap of $856.7 million and a P/E ratio of 37.81.
Omnicell (NASDAQ:OMCL) last released its earnings data on Thursday, August 1st. The company reported $0.27 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.25 by $0.02. The company had revenue of $93.70 million for the quarter, compared to the consensus estimate of $92.42 million. During the same quarter last year, the company posted $0.20 earnings per share. Omnicell’s revenue was up 24.3% compared to the same quarter last year.
Several analysts have recently commented on the stock. Analysts at B. Riley downgraded shares of Omnicell (NASDAQ:OMCL) from a “buy” rating to a “neutral” rating in a research note to investors on Thursday, September 26th. They now have a $26.00 price target on the stock. They noted that the move was a valuation call. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Omnicell (NASDAQ:OMCL) in a research note to investors on Wednesday, August 21st. They now have a $24.00 price target on the stock. Finally, analysts at Cowen and Company raised their price target on shares of Omnicell (NASDAQ:OMCL) from $18.00 to $21.00 in a research note to investors on Friday, August 2nd. They now have a “market perform” rating on the stock. Four investment analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $23.00.
Omnicell, Inc (NASDAQ:OMCL) is a provider of automated solutions for hospital medication and supply management.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.